Signed in as:
filler@godaddy.com
Empowering Rare Disease Teams with RAQA Expertise
Navigating the path to bring therapies to patients with rare diseases requires specialized knowledge and skills. The unique scientific, regulatory, and operational challenges demand expertise that goes beyond standard industry training.
As a dedicated non-profit partner, Regal Intel is committed to building capacity within the rare disease ecosystem.
Our training programs are designed to empower your team—whether in a non-profit foundation, academic center, or biotech company—with the practical regulatory affairs and quality assurance (RAQA) expertise needed to effectively advance your mission.
Our Training Philosophy: Practical Application for Rare Disease Challenges
Our Training Philosophy: Practical Application for Rare Disease Challenges
Regal Intel's training approach is rooted in practicality and focused on real-world application within the rare disease context. We go beyond theory, concentrating on how to apply regulatory and quality principles to solve the unique problems encountered when developing therapies for small populations, utilizing novel modalities (like ATMPs), or working with limited resources. Our instructors are industry veterans with direct experience navigating these specific challenges, providing insights that are relevant, actionable, and mission-focused. We utilize interactive learning, case studies based on rare disease scenarios, and practical exercises to ensure participants gain deep understanding and the ability to implement effective, compliant strategies.
Customized Training Programs for Your Mission
Our Training Philosophy: Practical Application for Rare Disease Challenges
Customized Training Programs for Your Mission
We recognize that every organization working in the rare disease space has unique needs and faces distinct hurdles. Regal Intel collaborates with you to develop and deliver tailored training programs designed to meet your specific objectives. Whether addressing challenges related to advanced therapies, specific regulatory pathways, scaling operations, or implementing efficient quality systems, our customized programs target your team's knowledge gaps and strategic goals, ensuring maximum relevance and impact for your mission.
Flexible Training Modules
Our Training Philosophy: Practical Application for Rare Disease Challenges
Customized Training Programs for Your Mission
To accommodate the demanding schedules of teams working on rare diseases, Regal Intel offers flexible training solutions, including modules covering key RAQA topics. These can be delivered onsite or adapted for other formats, providing accessible learning opportunities designed to enhance professional development and practical skills without significant disruption to critical program activities.
On-Demand Training Modules
Why Choose Regal Intel for Rare Disease Training?
Representative Training Topics
Regal Intel has developed a suite of onsite training modules covering key regulatory topics. These modules provide the flexibility and accessibility your team needs to learn face to face. Covering crucial topics, these modules provide accessible learning that enhances professional development.
Representative Training Topics
Why Choose Regal Intel for Rare Disease Training?
Representative Training Topics
Key Training Areas:
Our training covers foundational principles and specialized topics critical for success in the rare disease field:
Foundational Standards & Regulations:
Quality Management Systems (ISO 13485, ISO 9001)
Relevant Good Practices (cGMP [21 CFR 210/211, 820, EU Vol 4 + ATMP Annex], GCP [ICH E6], GLP, GDP)
Risk Management for Medical Devices (ISO 14971)
Rare Disease Regulatory Pathways & Strategy:
Orphan Drug Regulations & Application Strategies (US FDA, EMA, other global agencies)
Leveraging Expedited Pathways (e.g., Fast Track, BTD, RMAT, PRIME, Accelerated Approval)
Pediatric Regulations & Planning (PIP/PSP)
Global Rare Disease Registration Strategies
Humanitarian Use Device (HUD/HDE) Pathway (US)
Specific Modality Considerations:
CMC & Quality Requirements for Biologics and Advanced Therapies (Cell/Gene)
Compliance for Radiopharmaceuticals
Device/Diagnostic Compliance (EU MDR/IVDR) in Rare Disease Settings
Core Quality Processes:
Effective Risk Management Application
CAPA Management & Problem Solving
Auditing Techniques (Internal, Supplier Qualification)
Design Controls Implementation
Specialized Compliance (as applicable):
Halal, Kosher, Animal-Origin Free Requirements
Process Improvement for Efficiency:
Lean Six Sigma Methodologies (Yellow/Green/Black Belt)
We offer flexible training formats and develop bespoke programs to address your unique knowledge gaps. Partner with us to build specialized regulatory and quality excellence within your organization, strengthening your ability to serve the rare disease community.
Why Choose Regal Intel for Rare Disease Training?
Why Choose Regal Intel for Rare Disease Training?
Why Choose Regal Intel for Rare Disease Training?
Rare Disease Expert Instructors: Training delivered by industry veterans possessing direct, real-world experience in rare disease development, regulation, and quality management.
Practical Application Focus: Emphasis on hands-on learning and implementing knowledge to solve specific challenges encountered in rare disease programs.
Tailored & Mission-Focused Solutions: Customized training programs designed for the unique needs, context, scale, and strategic goals of organizations dedicated to rare diseases.
Relevant & Comprehensive Coverage: In-depth training on the key regulatory and quality topics most critical for achieving compliance and success in the rare disease field.
Global Perspective: Insights into international regulatory requirements and best practices applicable to bringing rare disease therapies to patients worldwide.
Community Focused: As a non-profit, we are committed to fostering expertise and sharing knowledge to strengthen the entire rare disease ecosystem.
Cost-Effective Options: Providing high-value training solutions designed with an understanding of the resource considerations common within the rare disease community.